Centres and Institutions
The Hull York Medical School is a partnership between the Universities of Hull and York, with newly-equipped teaching and learning facilities on the main campuses of both universities.
A leading university with a reputation as an academic powerhouse with a clear focus on excellence.
Y&H AHSN is focused on adopting and spreading proven innovation, research and evidence at pace and scale – improving clinical outcomes through driving behaviour change, building collaboration and encouraging enterprise and investment.
A collaboration to put research into clinical practice.
With over £8m of capital equipment, 2000m² of laboratories and 19 expert staff, this purpose-built centre of excellence provides access to state-of-the-art bioscience technologies for external academic laboratories and commercial business users.
YNiC has become the hub of a multi-disciplinary approach to understanding structural, chemical, functional and theoretical aspects of neuronal mechanisms.
CHE is a world renowned institute that produces policy relevant research and innovative methods that advance the use of health economics to improve population health.
A new £6.8m centre based across the Universities of Leeds and York will aim to transform diagnosis and treatment of patients suffering from cancer, heart disease and musculoskeletal diseases.
Carries out routine linkage of diagnostic and prognostic data to information on outcome and treatment into haematological cancer.
The Daisy Research Laboratories are located in the Daisy Building at Castle Hill Hospital Hull. Research groups include Cancer Proteomics, head and neck cancer, and respiratory medicine.
This provides consultancy and research in health economics to the NHS and the pharmaceutical and health care industries. It combines rigorous research standards with efficient project delivery.
York Trials Unit provides support and academic leadership for rigorous trial design, from a single service, such as telephone randomisation, through to all aspects of trial management via its research team.
The CII conducts research ranging from fundamental studies on the pathogenesis of infectious and non-infectious disease through to first-in-human clinical studies.
C2D2 is an institution-wide 'virtual centre' for coordinating, promoting, supporting and maximising the benefit of interdisciplinary research and research-linked activities in the area of chronic diseases and disorders.
Combining the insight and knowledge of immunologists, engineers, computer scientists and mathematicians, the YCIL investigates complex immune processes through computer simulations.
Research within CHyM focuses on the development and application of hyperpolarisation techniques for use in NMR and MRI.
The BPSI serves to stimulate and fund exciting new collaborative activities at the cutting-edge interface between the physical and life sciences.
YSBL looks at the fundamental chemical bases for biological and biochemical processes, the use of small molecules to probe cellular biology and software and methods development.
The York Plasma Institute brings together plasma scientists across a broad range of areas.
The Nanocentre is an interdisciplinary research and teaching centre.
Hull and East Yorkshire Hospitals employ around 8,000 staff and welcome around one million patients through their doors every year.
Castle Hill Hospital accommodates the Queen's Centre for Oncology and Haematology, Cardiac and Elective Surgical facilities.
The Hull Royal Infirmary site has 709 beds and is the main centre for Emergency work at the Trust.